BioSpectrum Asia Rivista Abbonamenti Online

Article“Cus­tom­ers are increas­ingly seek­ing part­ners to com­bine local tech­nical sup­port with global innov­a­tion cap­ab­il­it­ies” JEANINE HURRY

ArticleAPPROVED, CODED, LISTED: China’s

neur­o­tech speed run

ArticleNeur­o­logy’s Dis­ease-Modi­fy­ing Moment

Neur­o­logy is mov­ing from a his­tory of high-risk fail­ures to a period of unpre­ced­en­ted thera­peutic exper­i­ment­a­tion. For dec­ades, the com­plex­ity of the brain, lim­ited under­stand­ing of dis­ease bio­logy and the for­mid­able blood-brain...

ArticleAarthi Jana­kira­man,

From Micro­bi­ome to Mind: APAC's Push to Make the Gut-Brain Axis Clin­ic­ally Action­able Research Dir­ector, Advanced SciTech, Everest Group, India

ArticleAsia4EGMfiG’s

Alzheimer’s Bot­tle­neck Is Triage, Not Treat­ment Dr David Wilson, Vice Pres­id­ent, Clin­ical Strategy, Quan­terix, USA

ArticleInside China’s Neur­o­tech Revolu­tion Neeraj Nitin Jadhav,

Article“There is a grow­ing trend towards stronger loc­al­isa­tion, driven largely by global sup­ply chain risks and dis­rup­tions”

Article“Mov­ing cus­tom­ers from estab­lished, lower-cost altern­at­ives require clear, applic­a­tion-rel­ev­ant edu­ca­tion”